Pigmentary Disorders

Latest News

Melasma Significantly Impacts Quality of Life Among Patients With Darker Skin Types
Melasma Significantly Impacts Quality of Life Among Patients With Darker Skin Types

December 1st 2023

Investigators also developed a MELASQoL model using 4 predictors of quality of life impacts in patients with melasma.

Reviewing Common Facial, Bodily Pigmented Dermatoses in Varying Clinical Presentations
Reviewing Common Facial, Bodily Pigmented Dermatoses in Varying Clinical Presentations

October 28th 2023

Treating and Preventing Postinflammatory Hypo- and Hyperpigmentation
Treating and Preventing Postinflammatory Hypo- and Hyperpigmentation

August 18th 2023

Improving the Quality of Life for Patients With Albinism
Improving the Quality of Life for Patients With Albinism

July 26th 2023

Blue Light Irradiation Induces Minimal Pigmentation Change in Patients With Melasma
Blue Light Irradiation Induces Minimal Pigmentation Change in Patients With Melasma

July 10th 2023

Video Interviews
Podcasts
The Cutaneous Connection: Deep Dive Into the World of Vitiligo
Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

View More

More News

© 2023 MJH Life Sciences

All rights reserved.